vs
Aveanna Healthcare Holdings, Inc.（AVAH）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Aveanna Healthcare Holdings, Inc.的2.3倍（$1.4B vs $621.9M）。通用电气医疗净利率更高（3.6% vs 2.3%，领先1.3%）。Aveanna Healthcare Holdings, Inc.同比增速更快（22.2% vs 12.2%）。过去两年Aveanna Healthcare Holdings, Inc.的营收复合增速更高（14.0% vs 13.0%）
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
AVAH vs OPCH — 直观对比
营收规模更大
OPCH
是对方的2.3倍
$621.9M
营收增速更快
AVAH
高出9.9%
12.2%
净利率更高
OPCH
高出1.3%
2.3%
两年增速更快
AVAH
近两年复合增速
13.0%
损益表 — Q3 2026 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $621.9M | $1.4B |
| 净利润 | $14.1M | $51.8M |
| 毛利率 | 32.6% | 19.0% |
| 营业利润率 | 8.6% | 5.9% |
| 净利率 | 2.3% | 3.6% |
| 营收同比 | 22.2% | 12.2% |
| 净利润同比 | 132.8% | -3.8% |
| 每股收益（稀释后） | $0.06 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVAHOPCH
| Q3 25 | $621.9M | $1.4B | ||
| Q2 25 | $589.6M | $1.4B | ||
| Q1 25 | $559.2M | $1.3B | ||
| Q4 24 | $519.9M | $1.3B | ||
| Q3 24 | $509.0M | $1.3B | ||
| Q2 24 | $505.0M | $1.2B | ||
| Q1 24 | $490.7M | $1.1B | ||
| Q4 23 | $478.8M | $1.1B |
净利润AVAHOPCH
| Q3 25 | $14.1M | $51.8M | ||
| Q2 25 | $27.0M | $50.5M | ||
| Q1 25 | $5.2M | $46.7M | ||
| Q4 24 | $29.2M | $60.1M | ||
| Q3 24 | $-42.8M | $53.9M | ||
| Q2 24 | $13.9M | $53.0M | ||
| Q1 24 | $-11.2M | $44.8M | ||
| Q4 23 | $-25.7M | — |
毛利率AVAHOPCH
| Q3 25 | 32.6% | 19.0% | ||
| Q2 25 | 35.8% | 19.0% | ||
| Q1 25 | 32.8% | 19.7% | ||
| Q4 24 | 33.0% | 21.3% | ||
| Q3 24 | 31.4% | 20.1% | ||
| Q2 24 | 31.3% | 20.3% | ||
| Q1 24 | 29.7% | 20.8% | ||
| Q4 23 | 31.0% | 22.0% |
营业利润率AVAHOPCH
| Q3 25 | 8.6% | 5.9% | ||
| Q2 25 | 13.6% | 5.8% | ||
| Q1 25 | 9.3% | 5.9% | ||
| Q4 24 | 8.8% | 6.9% | ||
| Q3 24 | 6.7% | 6.7% | ||
| Q2 24 | 7.4% | 6.6% | ||
| Q1 24 | 4.7% | 6.0% | ||
| Q4 23 | 6.1% | 7.5% |
净利率AVAHOPCH
| Q3 25 | 2.3% | 3.6% | ||
| Q2 25 | 4.6% | 3.6% | ||
| Q1 25 | 0.9% | 3.5% | ||
| Q4 24 | 5.6% | 4.8% | ||
| Q3 24 | -8.4% | 4.2% | ||
| Q2 24 | 2.8% | 4.3% | ||
| Q1 24 | -2.3% | 3.9% | ||
| Q4 23 | -5.4% | — |
每股收益（稀释后）AVAHOPCH
| Q3 25 | $0.06 | $0.32 | ||
| Q2 25 | $0.13 | $0.31 | ||
| Q1 25 | $0.03 | $0.28 | ||
| Q4 24 | $0.15 | $0.36 | ||
| Q3 24 | $-0.22 | $0.31 | ||
| Q2 24 | $0.07 | $0.30 | ||
| Q1 24 | $-0.06 | $0.26 | ||
| Q4 23 | $-0.13 | $0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.9M | $309.8M |
| 总债务越低越好 | $1.3B | $1.2B |
| 股东权益账面价值 | $9.2M | $1.4B |
| 总资产 | $1.8B | $3.5B |
| 负债/权益比越低杠杆越低 | 141.83× | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资AVAHOPCH
| Q3 25 | $145.9M | $309.8M | ||
| Q2 25 | $100.7M | $198.8M | ||
| Q1 25 | $71.5M | $171.4M | ||
| Q4 24 | $84.3M | $412.6M | ||
| Q3 24 | $78.5M | $483.0M | ||
| Q2 24 | $47.7M | $376.9M | ||
| Q1 24 | $42.6M | $219.5M | ||
| Q4 23 | $43.9M | $343.8M |
总债务AVAHOPCH
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | $1.3B | $1.1B | ||
| Q4 23 | $1.3B | $1.1B |
股东权益AVAHOPCH
| Q3 25 | $9.2M | $1.4B | ||
| Q2 25 | $-12.0M | $1.4B | ||
| Q1 25 | $-100.1M | $1.4B | ||
| Q4 24 | $-123.6M | $1.4B | ||
| Q3 24 | $-156.4M | $1.4B | ||
| Q2 24 | $-119.0M | $1.4B | ||
| Q1 24 | $-136.3M | $1.4B | ||
| Q4 23 | $-129.6M | $1.4B |
总资产AVAHOPCH
| Q3 25 | $1.8B | $3.5B | ||
| Q2 25 | $1.8B | $3.4B | ||
| Q1 25 | $1.7B | $3.3B | ||
| Q4 24 | $1.7B | $3.4B | ||
| Q3 24 | $1.6B | $3.4B | ||
| Q2 24 | $1.7B | $3.3B | ||
| Q1 24 | $1.6B | $3.2B | ||
| Q4 23 | $1.6B | $3.2B |
负债/权益比AVAHOPCH
| Q3 25 | 141.83× | 0.86× | ||
| Q2 25 | — | 0.82× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | — | 0.79× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.74× | ||
| Q4 23 | — | 0.75× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.2M | $139.4M |
| 自由现金流经营现金流 - 资本支出 | — | $130.2M |
| 自由现金流率自由现金流/营收 | — | 9.1% |
| 资本支出强度资本支出/营收 | — | 0.6% |
| 现金转化率经营现金流/净利润 | 2.36× | 2.69× |
| 过去12个月自由现金流最近4个季度 | — | $220.7M |
8季度趋势，按日历期对齐
经营现金流AVAHOPCH
| Q3 25 | $33.2M | $139.4M | ||
| Q2 25 | $51.6M | $90.3M | ||
| Q1 25 | $-8.6M | $-7.2M | ||
| Q4 24 | $13.4M | $36.1M | ||
| Q3 24 | $29.4M | $160.4M | ||
| Q2 24 | $1.8M | $195.7M | ||
| Q1 24 | $-12.0M | $-68.8M | ||
| Q4 23 | $-3.0M | $51.0M |
自由现金流AVAHOPCH
| Q3 25 | — | $130.2M | ||
| Q2 25 | — | $81.2M | ||
| Q1 25 | — | $-16.6M | ||
| Q4 24 | — | $25.8M | ||
| Q3 24 | — | $150.7M | ||
| Q2 24 | — | $185.9M | ||
| Q1 24 | — | $-74.6M | ||
| Q4 23 | — | $31.1M |
自由现金流率AVAHOPCH
| Q3 25 | — | 9.1% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | -1.2% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | — | -6.5% | ||
| Q4 23 | — | 2.8% |
资本支出强度AVAHOPCH
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.5% | ||
| Q4 23 | — | 1.8% |
现金转化率AVAHOPCH
| Q3 25 | 2.36× | 2.69× | ||
| Q2 25 | 1.91× | 1.79× | ||
| Q1 25 | -1.66× | -0.15× | ||
| Q4 24 | 0.46× | 0.60× | ||
| Q3 24 | — | 2.98× | ||
| Q2 24 | 0.13× | 3.69× | ||
| Q1 24 | — | -1.54× | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
